Case Study: The Challenges Of The Innovative Exosomes-Based Therapies
Time: 11:30 am
day: Conference Day Two
Details:
- Highlighting the key advantages but also challenges of continuing development of exosome-based therapies
- Understanding the regulatory pathway and why exosomes are not considered as ATMP
- Learning how ExoBiologics became the first company authorized by the EMA for clinical trials of MSC derived exosomes
